2017年4月24日
Illumina在2017年1月的JP摩根健康大会上发布了NovaSeq系列。该系列无可匹敌的通量、友好的工作流程、每个样本的低成本以及无与伦比的灵活性已经吸引了大量客户的关注。
自产品发布以来，我们从客户那里了解到，他们希望能够分别处理流动槽上的各个通道，这样的话就可以更简便地上样不同类型的文库、应用和样本。今天，我们正式宣布正在积极开发配套装置和相关耗材来提供此项功能。该新的工作流程将兼容NovaSeq系列的所有流动槽，客户可以在各个通道中上样不同的项目和文库（包括各种测序应用），在一个通道中实现复合扩增，在增强综合多重功能的同时降低了每次运行所需的DNA起始量。
提供这一新流程功能的相关耗材和装置预计将在2017年第四季度上市。
Forward-Looking Statements
This release contains forward-looking statements that involve risks and uncertainties. Examples of forward-looking statements include, but are not limited to, statements we make regarding the expected availability dates for new products and services and FDA submission dates and intentions for certain products and services. Important factors that could cause actual results to differ materially from those in any forward-looking statements include challenges inherent in developing, manufacturing, and launching new products and services, and the other factors that are detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We do not intend to update any forward-looking statements after the date of this release.
For Research Use Only. Not for use in diagnostic procedures.
